The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells

Published:2010-07 Issue:1 Volume:118 Page:64-68
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Cadron Isabelle,Van Gorp Toon,Mihalyi Attila,Luyten Catherina,Drijkoningen Katrien,Amant Frederic,Leunen Karin,Vergote Ignace

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference17 articles.

1. The protein kinase Cβ-selective inhibitor, Enzastaurin (LY317615.HCl) suppresses signalling through the AKT pathway, induces apoptosis and suppresses growth of human colon cancer and glioblastoma xenografts;Graff;Cancer Res,2005

2. Enzastaurin (LY317615HCl), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines;Rizvi;Mol Cancer Ther,2006

3. The selective protein kinase Cβ inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway;Querfeld;J Investig Dermatol,2006

4. CA125 production and release by ovarian cancer cells in vitro;Beck;Int J Biol Markers,1998

5. The biology and clinical relevance of the PTEN tumor suppressor pathway;Sansal;J Clin Oncol,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boosting edgeR (Robust) by dealing with missing observations and gene-specific outliers in RNA-Seq profiles and its application to explore biomarker genes for diagnosis and therapies of ovarian cancer;Genomics;2024-05

2. Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin;Bioscience Reports;2017-03-27

3. Intra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and Metastasis;Biomolecules;2016-10-13

4. Novel therapies, including enzastaurin, in the treatment of ovarian cancer;Expert Opinion on Investigational Drugs;2014-03-22

5. Mucins in pancreatic cancer and its microenvironment;Nature Reviews Gastroenterology & Hepatology;2013-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3